EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0525
-0.0086 (-14.08%)
At close: Mar 31, 2026
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $536.83 thousand as of April 14, 2026. Its market cap has decreased by -95.17% in one year.
Market Cap
536.83K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 536.83K, a decrease of -99.24%. That is a compound annual growth rate of -36.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 536.83K | -35.27% |
| Dec 31, 2025 | 829.28K | -15.08% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windtree Therapeutics | 755.80K |
| Iterum Therapeutics | 734.41K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 701.88K |
| Scorpius Holdings | 611.43K |
| Bio-Path Holdings | 588.56K |
| Hepion Pharmaceuticals | 518.50K |
| Eloxx Pharmaceuticals | 424.01K |